From Molecule to Medicine: Pioneering Statistical Innovation in Oncology Trials
Cancer research has advanced significantly in recent years, and statistics have played a crucial role in this progress. Oncology trials rely on data-driven methods to test new drugs safely and efficiently. Moving from molecule discovery to approved medicine requires careful planning, strong models, and innovative trial designs. Statistical innovation in oncology trials enables this by […]
Read More